: Companies like Roche and Amgen are leading the way by investing hundreds of millions into AI-driven drug discovery. If you'd like to refine your investment strategy , tell me:
: Boasts strong return ratios (ROE ~19%) and is moving into the US specialty space with upcoming NDA filings. which pharma stock to buy
The 2026 Pharma Playbook: Stability Meets High-Growth Innovation : Companies like Roche and Amgen are leading
Traction in and global contract manufacturing. Laurus Labs Commercial ramp-up in its new manufacturing facilities. Ajanta Pharma Niche leadership in ophthalmology and zero debt. The "Value" Opportunity: Undervalued Contenders conservative large-caps or high-risk R&D specialists).
Your preferred (e.g., short-term momentum or 5+ year growth).
Your (e.g., conservative large-caps or high-risk R&D specialists).